Literature DB >> 11276001

Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast.

C E Gillett1, D W Miles, K Ryder, D Skilton, R D Liebman, R J Springall, D M Barnes, A M Hanby.   

Abstract

Many studies have investigated the relationship between the E-cadherin/catenin axis and breast cancer biology and yet, unlike the studies in other tumour systems, which have shown a relationship between down-regulation and poor survival, no clear association has emerged in breast. Since accumulating evidence suggests that ductal carcinoma of no special type (NST) represents a diverse group of biologies, this study has focused on grade III ductal carcinoma, in order to reduce the heterogeneity of the study population. A total of 470 breast tumours were studied. Consecutive sections were labelled with antibodies which recognize E-cadherin and the arm proteins with which it interacts: alpha-, beta-, and gamma-catenin. Membrane-bound and cytoplasmic E-cadherin and membrane-bound alpha-catenin expression were associated with a positive oestrogen receptor (ER) status, gamma-catenin with a negative ER status, and, surprisingly, all three with poor survival. Taken together, these findings suggest that a conserved E-cadherin/catenin axis may play a part in determining adverse outcome in grade III breast carcinoma. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276001     DOI: 10.1002/path.831

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  28 in total

Review 1.  Preinvasive breast cancer.

Authors:  Dennis C Sgroi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

2.  Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer.

Authors:  Rosa Murria; Sarai Palanca; Inmaculada de Juan; Cecilia Egoavil; Cristina Alenda; Zaida García-Casado; María J Juan; Ana B Sánchez; Ana Santaballa; Isabel Chirivella; Ángel Segura; David Hervás; Marta Llop; Eva Barragán; Pascual Bolufer
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  Wild-type BRCA1, but not mutated BRCA1, regulates the expression of the nuclear form of beta-catenin.

Authors:  Huchun Li; Masayuki Sekine; Nadine Tung; Hava Karsenty Avraham
Journal:  Mol Cancer Res       Date:  2010-03-09       Impact factor: 5.852

4.  Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.

Authors:  Andrey I Khramtsov; Galina F Khramtsova; Maria Tretiakova; Dezheng Huo; Olufunmilayo I Olopade; Kathleen H Goss
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

Review 5.  The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases.

Authors:  Kasoha Mariz; Juhasz-Böss Ingolf; Herr Daniel; Ney Jasmin Teresa; Solomayer Erich-Franz
Journal:  Clin Exp Metastasis       Date:  2015-09-29       Impact factor: 5.150

6.  Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine.

Authors:  Rosa Murria; Sarai Palanca; Inmaculada de Juan; Cristina Alenda; Cecilia Egoavil; Francisco J Seguí; Zaida García-Casado; María J Juan; Ana B Sánchez; Ángel Segura; Ana Santaballa; Isabel Chirivella; Marta Llop; Gema Pérez; Eva Barragán; Dolores Salas; Pascual Bolufer
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

7.  Expression of e-cadherin in high-risk breast cancer.

Authors:  Eugene M Howard; Stephen K Lau; Robert H Lyles; George G Birdsong; Jay N Umbreit; Ruby Kochhar
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-01       Impact factor: 4.553

8.  Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.

Authors:  M Burkhardt; E Mayordomo; K-J Winzer; F Fritzsche; T Gansukh; S Pahl; W Weichert; C Denkert; H Guski; M Dietel; G Kristiansen
Journal:  J Clin Pathol       Date:  2006-02-16       Impact factor: 3.411

9.  Altered expression of β-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma.

Authors:  Rahul Bhagat; C S Premalata; V Shilpa; V R Pallavi; G Ramesh; C R Vijay; Lakshmi Krishnamoorthy
Journal:  Tumour Biol       Date:  2013-04-19

10.  Rearrangements of the actin cytoskeleton and E-cadherin-based adherens junctions caused by neoplasic transformation change cell-cell interactions.

Authors:  Dmitry V Ayollo; Irina Y Zhitnyak; Jury M Vasiliev; Natalya A Gloushankova
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.